Comparison of serum survivin and alpha fetoprotein in Egyptian patients with hepatocellular carcinoma associated with hepatitis C viral infection

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 4, 2010, Pages 897-903

  El Attar, H A ^a   Kandil, M H ^a   El Kerm, Y M ^a   El Ghandour, M K ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Alpha fetoprotein; Apoptosis; Hepatocellular carcinoma; Survivin

Indexed keywords

EID: 78650713201     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Altieri DC, Marchisio C. (1999). Survivin apoptosis: an interloper between cell death andcell proliferation in cancer. Lab Invest, 79, 1327-33.
2. Asanuma H, Torigoe T, Kamiguchi K, et al (2005). Survivin expression is regulated by coexpression of human epidermal growth factor receptor-2 and epidermal growth factor receptor via phosphatidylinositol 3-Kinase/AKT signaling pathway in breast cancer cells. Cancer Res, 65, 11018-25.
3. Befeler AS, Di Bisceglie AM. (2002). Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology, 122, 1609-19.
4. Bishop ML, Fody EP, Schoeff L. (2005). Clinical chemistry. principle, procedures, correlations. 5th Ed. Lippincott Williams & Wilkins. United States of America, 152-3, 156.
5. Bokarewa M, Lindblad S, Bokarew D et al (2005). Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis. Arthritis Res Ther, 7, R349-58.
6. Bosch FX, Ribes J, Cleries R, et al (2005). Epidemiology of hepatocellular carcinoma. Clin Liver Dis, 9, 191- 211.
7. Burtis CA, Ashwood ER, Bruns DE. (2006). Tietz textbook of clinical chemistry and molecular diagnostics. 4th Ed. Elsevier Saunders Company. Philadelphia, 798, 586-7, 548, 1195-8, 604-7, 609-10, 613, 717, 1801-3, 547, 608.
8. Chang JT, Wong F-H, Liao C-T, et al (2004). Enzyme immunoassay for serum autoantibody to survivin and its findings in head-and-neck cancer patients. Clin Chem, 50, 1261-4.
9. Chiou S-K, Mandayam S. (2007). NSAIDs enhance proteasomic degradation of Survivin a mechanism of gastric epithelialcell injury and apoptosis. Biochem Pharmacol, 74, 1485-95.
10. Cui F, Chen B, Chen JZ, et al (2008). Expressions of Survivin and vascular endothelial growth factor in hepatocellular carcinoma and their clinical significance. Nan Fang Yi Ke Da Xue Xue Bao, 28, 761-3.
11. Derin D, Soydinç HO, Guney N, et al (2008). Serum levels of apoptosis biomarkers, survivin and TNF-alpha in non small cell lung cancer. Lung Cancer, 59, 240-5.
12. Di Maio M, Daniiele B, Pignata S, et al (2008). Is human hepatocellular carcinoma a hormone-responsive tumor? World J Gastroenterol, 14, 1682-9.
13. Duffy MJ, O'Donovan N, Brennan DJ, et al (2007). Survivin: a promising tumor biomarker. Cancer Lett, 249, 49-60.
14. El-Zayadi AR, Abaza H, Shawky S, et al (2001). Prevalence and epidemiological features of hepatocellular carcinoma in Egypt-a single center experience. Hepatol Res, 19, 170-9.
15. Ezzat S, Abdel-Hamid M, Eissa SA, et al (2005). Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt. Int J Hyg Environ Hlth, 208, 329-39.
16. Feldman M, Friedman LS, Sleisenger MH. (2002). Sleisenger & Fordtrans. Gastrointestinal and liver disease. 7th Ed. WB Saunders Company. Philadelphia, 1263, 1303, 588.
17. Fields AC, Cotsonis G, Sexton D, et al (2004). Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters and outcome. Mod Pathol, 17, 1378-85.
18. Filmus J, Capurro M. (2004). Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma. Mol Diagn, 8, 207-12.
19. Fukuda S, Pelus LM. (2006). Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther, 5, 1087-98.
20. Goksel G, Tanelif F, Uslu R, et al (2007). Serum her2/neu and survivin levels and their relationship to histological parameters in early-stage breast cancer. J Int Med Res, 35, 165-72.
21. Hui W, Zan Y, Wang X, et al (2008). Expression of Survivin, p53 and its relationship with apoptosis, proliferation in hepatocellular carcinoma(HCC). J Nanjing Med Univ, 22, 255-9.
22. Ikeguchi M, Hirooka Y, Kaibara N. (2002). Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma. Cancer, 95, 1938-45.
23. Ito T, Shirakiki K, Sugimoto K, et al (2000). Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology, 31, 1080-5.
24. Kappler M, Kotzsch M, Bartel F, et al (2001). Elevated expression level of survivin protein in soft tissue sarcomas is a strong independent predictor of survival. Int J Cancer, 95, 360-72.
25. Kobayashi Y, Yukiue H, Sasaki H, et al (2002). Developmentally regulated expression of survivin in human thymus. Human Immun, 63, 101-7.
26. Lewis SM, Bain BJ, Bates I. (2001). Dacie and Lewis. Practical Hematology Textbook. 9th Ed. Harcourt publishers limited. London, 30-41.
27. Mamori S, Asakura T, Ohkawa K, et al (2007). Survivin expression in hepatocellular carcinoma and post-treatment with anti-cancer drug under hypoxic culture Condition. World J Gastroenterol, 13, 5306-11.
28. Montorsi M, Maggioni M, Falleni M, et al (2007). Survivin gene expression in chronic liver disease and hepatocellular carcinoma. Hepatogastroenterology, 54, 2040-4.
29. Parkin DM. (2000). Global cancer statistics in the year 2000. Lancet Oncol, 2, 533-43.
30. Sarela AI, Macadam RC, Farmery SM, et al (2000). Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut, 46, 645-50.
31. Takehara T, Liu X, Fujimoto J, et al (2001). Expression and role of Bcl- xL in human hepatocellular carcinomas. Hepatology, 34, 55-61.
32. Tong M, Blatt L, Kao V. (2001). Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America. J Gastroenterol Hepatol, 16, 553-9.
33. th Ed. Heinmann Medical Books Ltd. London 1980, 405.
34. Vetter CS, Muller-Blech K, Schrama D, et al (2005). Cytoplasmic and nuclear expression of survivin in melanocytic skin lesions. Arch Dermatol Res, 297, 26-30.
35. Wang Y, Suominen J, Hakovirta H, et al (2004). Survivin expression in rat testis is up-regulated by stem cell factor. Mol Cell Endocrinol, 218, 165-74.
36. Yagihashi A, Asanuma K, Kobayashi D, et al (2005). Autoantibodies to survivin in patients with chronic hepatitis and hepatocellular carcinoma. Autoimmunity, 38, 445-8.
37. Ye C-P, Qiu C-Z, Huang Z-X, et al (2007). Relationship between survivin expression and recurrence, and prognosis in hepatocellular carcinoma. World J Gastroenterol, 13, 6264-8.
38. Zhu H, Chen X-P, Zhang W-G, et al (2005). Expression and significance of new inhibitor of apoptosis protein survivin in hepatocellular carcinoma. World J Gastroenterol, 11, 3855-9.